Loading clinical trials...
Loading clinical trials...
Allogeneic HSCT in 17p- CLL in First or Second Partial or Complete Remission at Transplant: a Non-interventional Prospective Study.
Conditions
Locations
10
Denmark
Rigshospitalitet
Copenhagen, Denmark
University Central Hospital
Helsinki, Finland
Universitaetsklinikum
Dresden, Germany
University Hospital Eppendorf
Hamburg, Germany
University of Heidelberg
Heidelberg, Germany
Klinik fuer Innere Medzin III
Ulm, Germany
Start Date
August 1, 2010
Primary Completion Date
September 1, 2015
Completion Date
December 31, 2015
Last Updated
August 16, 2019
NCT06859424
NCT06043011
NCT06528301
NCT02863692
NCT05168930
NCT06916767
Lead Sponsor
European Society for Blood and Marrow Transplantation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions